![](/img/cover-not-exists.png)
1080 Preclinical and Toxicological Assessments of the Novel Orally Bioavailable PPAR Ligand GED-0507-34-Levo for the Treatment of Inflammatory Bowel Disease
Christel Rousseaux, Caroline Dubuquoy, Salvatore Bellinvia, Francesca Viti, Jean-Frederic Colombel, Philippe Chavatte, Pierre DesreumauxVolume:
138
Year:
2010
Language:
english
DOI:
10.1016/s0016-5085(10)60721-4
File:
PDF, 101 KB
english, 2010